Table 1 Patient demographics
Intention-to-Treat | p value | Per-Protocol | p value | |||
|---|---|---|---|---|---|---|
NI-SV (n = 35) | MV (n = 35) | NI-SV (n = 32) | MV (n = 33) | |||
Age (year) | 58(47.5–65) | 58(52.5–65) | 0.810 | 58.5(47.5–66.5) | 58(52–65) | 0.963 |
Gender | 0.811 | 0.890 | ||||
Male | 16(45.7) | 17(48.6) | 14(43.8) | 15(45.5) | ||
Female | 19(54.3) | 18(51.4) | 18(56.3) | 18(54.5) | ||
Height (cm) | 166(160-171.5) | 166(160–170) | 0.799 | 165.5(160-171.5) | 166(160–170) | 0.827 |
Weight (kg) | 65(59.5–74) | 63(60-70.5) | 0.680 | 65(59.5–73) | 63(60–70) | 0.540 |
BMI (kg/m2) | 23.9(22.2–26.1) | 23.5(21.8–26.3) | 0.833 | 23.7(22.2–25.8) | 23.4(21.3–25.1) | 0.600 |
ASA grade | 0.806 | 0.724 | ||||
I | 14(40.0) | 13(37.1) | 13(40.6) | 12(36.4) | ||
II | 21(60.0) | 22(62.9) | 19(59.4) | 21(63.6) | ||
Comorbidities | ||||||
Diabetes mellitus | 5(14.3) | 3(8.6) | 0.710 | 4(12.5) | 3(9.1) | 0.482 |
Hypertension | 6(17.1) | 9(25.7) | 0.382 | 6(18.8) | 8(24.2) | 0.590 |
Preoperative lung function | ||||||
FVC (L) | 3.54(2.90–4.27) | 3.27(2.88–3.89) | 0.428 | 3.45(2.90–4.20) | 3.27(2.85–3.88) | 0.447 |
FEV1 (L) | 2.66(2.26–3.27) | 2.88(2.47–3.15) | 0.456 | 2.65(2.21–3.35) | 2.87(2.48–3.12) | 0.524 |
FEV1/FVC (%) | 79.6(73.2–82.3) | 80.2(76.6–84.0) | 0.310 | 79.5(73.2–82.3) | 80.2(77.3–83.3) | 0.319 |